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The onset of several silent, chronic diseases such as diabetes can
be detected only through diagnostic tests. Due to cost considerations,
self-reported outcomes are routinely collected in lieu of expensive di-
agnostic tests in large-scale prospective investigations such as the
Women’s Health Initiative. However, self-reported outcomes are sub-
ject to imperfect sensitivity and specificity. Using a semiparametric
likelihood-based approach, we present time to event models to esti-
mate the association of one or more covariates with a error-prone,
self-reported outcome. We present simulation studies to assess the
effect of error in self-reported outcomes with regard to bias in the
estimation of the regression parameter of interest. We apply the pro-
posed methods to prospective data from 152,830 women enrolled in
the Women’s Health Initiative to evaluate the effect of statin use with
the risk of incident diabetes mellitus among postmenopausal women.
The current analysis is based on follow-up through 2010, with a me-
dian duration of follow-up of 12.1 years. The methods proposed in
this paper are readily implemented using our freely available R soft-
ware package icensmis, which is available at the Comprehensive R
Archive Network (CRAN) website.
1. Introduction. The onset of several chronic diseases such as diabetes
are asymptomatic and can be detected only through diagnostic tests. For ex-
ample, diabetes can be detected by measuring levels of fasting blood glucose
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or glycosylated hemoglobin levels (HbA1c). However, the costs of such gold
standard diagnostic tests can be prohibitive in large-scale epidemiological
studies such as the Women’s Health Initiative (WHI) that enroll and fol-
low over a hundred thousand subjects. Disease prevalence and incidence in
large observational cohorts are often ascertained through error-prone, self-
reported questionnaires. In this paper, we propose a semiparametric model
to assess the association of specific covariates of interest with a silent time
to event outcome that is assessed through periodic, error-prone self-reports.
Using data from postmenopausal women enrolled in the WHI, the moti-
vating application in this paper is the evaluation of the hypothesis that the
use of cholesterol lowering medications (statins) can result in an increased
risk of diabetes. The WHI recruited women (N = 161,808) aged 50–79 at
40 clinical centers across the U.S. from 1993–1998 with ongoing follow-up
[Anderson et al. (1998)]. Prevalent and incident diabetes during the course
of follow-up was ascertained by self-report obtained at each annual visit. In
a recent paper, Culver et al. (2012) presented an analysis of the effects of
statin use on the risk of incident diabetes in the WHI using Cox proportional
hazards models. The analyses were conducted based on the assumption that
self-reported outcomes of prevalent and incident diabetes are error-free. The
validity of self-reports of incident and prevalent diabetes have been evalu-
ated using data from a substudy nested within the WHI—when compared
to fasting glucose levels (treated as the gold standard), diabetes self-reports
had a positive predictive value of 74% and negative predictive value of 97%
[Margolis et al. (2008), Jackson et al. (2014)]. Other studies such as the
Nurses’ Health Study, Physicians’ Health Study and the Finnish Public Sec-
tor Study also commonly use self-reported outcomes [He et al. (2010), Hu
et al. (2001), Oksanen et al. (2010)].
When a perfect diagnostic test is given sequentially at different points in
time to the same individual, the time until the event of interest can be deter-
mined to lie in the interval between the last negative test and the first pos-
itive test—that is, the time until the event is interval censored. In this con-
text, methods for estimating the survival distribution and assessing the ef-
fect of covariates have been developed [Turnbull (1976), Finkelstein (1986)].
However, when error-prone diagnostic procedures such as self-reports are
used, standard methods for interval censored outcomes are rendered invalid.
Previous work in this area includes methods for error-prone outcomes with
application to data collected from laboratory-based diagnostic tests in stud-
ies in HIV, HPV and STD [Balasubramanian and Lagakos (2001, 2003),
McKeown and Jewell (2010), Meier, Richardson and Hughes (2003)]. Bala-
subramanian and Lagakos (2003) developed a formal likelihood framework
to estimate the distribution of the time to mother to child transmission of
HIV. The proposed methods were applied to data from imperfect DNA PCR
diagnostic tests to detect the presence of HIV in infants who were born to
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HIV-positive pregnant women. Meier, Richardson and Hughes (2003) ex-
tended the discrete proportional hazard model to incorporate outcomes and
covariates. In related work, several papers proposed generalized Cox models
in settings involving time to event outcomes with incomplete event adjudica-
tion [Snapinn (1998), Cook (2000), Cook and Kosorok (2004)]. Other related
work includes that proposed by McKeown and Jewell (2010) in the context
of HPV studies, where the authors accommodate misclassification by incor-
porating ideas of binary generalized linear models with outcomes subject to
misclassification [Neuhaus (1999)]. The problem of error-prone time to event
outcomes can also be handled through the Hidden Markov Model (HMM)
framework. Previous applications of HMM-based methods include the areas
of breast cancer [Chen, Duffy and Tabar (1996)], HIV [Satten and Longini
(1996), Guihenneuc-Jouyaux, Richardson and Longini (2000)], lung trans-
plantation [Jackson and Sharples (2002)] and cervical smear tests [Kirby and
Spiegelhalter (1994)]. Jackson et al. (2003) present a general framework for
staged Markov models to handle misclassification due to error-prone screen-
ing tests. Other recent methodological advances within the general area of
outcomes measured with error include the papers by Garc´ıa-Zattera et al.
(2012) and Lyles et al. (2011), as well as works on covariate measurement
error with application to the WHI and the Nurses Health Study [Shaw and
Prentice (2012), Spiegelman, Rosner and Logan (2000)]. However, none of
the previous literature specifically considers error-prone, self-reported time
to event outcomes.
In this paper we present a likelihood-based approach to incorporate time-
varying covariate effects specific to the setting in which the prevalence and
incidence (time to event) of a chronic condition such as diabetes is ascer-
tained through error-prone self-reports. We incorporate the situation where
an unknown proportion of subjects who have already experienced the event
of interest at baseline are mistakenly included into the study, due to the use
of error-prone self-reports at study entry. We also provide a freely available
R software package and illustrate its use [Gu and Balasubramanian (2013)].
In Section 2 we present notation, form of the likelihood function, address
issues related to estimation and extensions to incorporate misclassification
of subjects at study entry. In Section 3 we perform simulation studies to
evaluate the effects of various degrees of error in self-reports. We investigate
the effects of erroneous inclusion of subjects who have already experienced
the event of interest due to imperfect negative predictive values associated
with self-reports. In Section 4 we evaluate the association between statin
use with the risk of incident diabetes in a subset of 152,830 women enrolled
in the WHI. Last, in Section 5 we discuss the findings of this study and
highlight future directions.
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2. Methods. In this section we present notation, form of the likelihood
and extensions to incorporate the possibility of misclassification at study
entry.
2.1. Notation, likelihood, estimation. Let X refer to the random variable
denoting the unobserved time to event for an individual, with associated
survival, density and hazard functions denoted by S(x), f(x) and λ(x), for
x ≥ 0, respectively. The time origin is set to 0, corresponding to the base-
line visit at which all subjects enrolled in the study are event-free. In other
words, Pr(X > 0) = 1. Without loss of generality, we set X =∞ when the
event of interest does not occur. Let N denote the number of subjects and
ni denote the number of visits for the ith subject. At each visit, we assume
that each subject would self-report their disease status. For example, in the
WHI, information on incident diabetes was collected at periodically sched-
uled visits using self-reported questionnaires. For the ith subject, we let Ri
and ti denote the 1×ni vectors of self-reported, binary outcomes and corre-
sponding visit times, respectively. In particular, Rij is equal to 1 if the jth
self-report for the ith subject is positive (indicating occurrence of the event
of interest such as diabetes) and 0 otherwise. We assume that self-reports
are collected at prescheduled visits up to the time of the first positive self-
report, thus, the vectors of test results (Ri), visit times (ti) and the number
of self-reports collected per subject (ni) are random. Let τ1, . . . , τJ denote
the distinct, ordered visit times in the data set among N subjects, where
0 = τ0 < τ1 < · · · < τJ < τJ+1 =∞, thus, the time axis can be divided into
J + 1 disjoint intervals, [0, τ1), [τ1, τ2), . . . , [τJ ,∞).
The joint probability of the observed data for the ith subject can be
expressed as
g(Ri, ti, ni) =
J+1∑
j=1
Pr(τj−1 <Xi ≤ τj)Pr(Ri, ti, ni|τj−1 <Xi ≤ τj)
=
J+1∑
j=1
θj Pr(Ri, ti, ni|τj−1 <Xi ≤ τj),
where θj =Pr(τj−1 <X ≤ τj), τ0 = 0 and τJ+1 =∞.
To simplify the form of the expression above, we make the assumption
that given the true time of event Xi, an individual’s ni self-reports are
independent. That is,
Pr(Ri|Xi, ti) =
ni∏
k=1
Pr(rik|Xi, tik).
This assumption implies that the observed values of other self-reported out-
comes do not provide additional information about the distribution of a
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particular self-reported outcome from that provided by the actual time of
the event.
Based on the derivation in Balasubramanian and Lagakos (2003), it can
be shown that the joint probability of the observed data for the ith subject
can be simplified as
g(Ri, ti, ni) =
J+1∑
j=1
θj
[
ni∏
k=1
Pr(rik|τj−1 <Xi ≤ τj, tk)
]
(2.1)
=
J+1∑
j=1
θjCij ,
where Cij = [
∏ni
k=1Pr(rik|τj−1 <Xi ≤ τj, tk)]. We assume that the proba-
bility of a positive self-report at the kth visit (rik = 1) conditional on the
interval containing the true event time and visit time can be expressed as
Pr(rik = 1|τj−1 <Xi ≤ τj , tk) =
{
ϕ1, tk ≥ τj ,
1−ϕ0, tk ≤ τj−1.
Here, ϕ1 and ϕ0 denote the sensitivity and specificity of self-reports, re-
spectively. Thus, the terms Cij , for j = 1, . . . , J + 1, in equation (2.1) can
be expressed as a product involving the constants ϕ1 and ϕ0. Thus, in the
absence of covariates, the log likelihood for a random sample of N subjects
can be expressed as
l(θ) = log(L(θ)) =
N∑
i=1
log
(
J+1∑
j=1
Cijθj
)
.(2.2)
For the special case where self-reports are perfect (ϕ1 = ϕ0 = 1), equation
(2.2) reduces to the nonparametric likelihood for interval censored observa-
tions given in Turnbull (1976).
In most settings, including the WHI, it is of interest to evaluate the as-
sociation of a vector of covariates with respect to the time to event of in-
terest. Let Z denote the P × 1 vector of explanatory variables with the
corresponding P ×1 vector of regression coefficients denoted by β. To incor-
porate the effect of covariates, we assume the proportional hazards model,
λ(t|Z= z) = λ0(t)e
z
′β, or, equivalently, S(t|Z= z) = S0(t)
ez
′β
.
To derive the form of the log-likelihood based on the assumption of the
proportional hazards model, we first reparameterize the log likelihood in
(2.2) in terms of the survival function, S = (1 = S1, S2, . . . , SJ+1)
T , where
Sj = Pr(X > τj−1). Since Sj =
∑J+1
l=j θl, the vector of interval probabilities
can be expressed as θ = TrS, where Tr is the (J+1)× (J+1) transformation
matrix. Let C = [Cij ] denote the N × (J +1) matrix of the coefficients, Cij ,
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and let the N×(J+1) matrix D be defined as DN×(J+1) =C×Tr. Then, the
log-likelihood function for the one-sample setting in (2.2) can be expressed
as
l(S) =
N∑
i=1
log
(
J+1∑
j=1
DijSj
)
,(2.3)
where S1 = 1 and S2, S3, . . . , SJ+1 are the unknown parameters of interest.
Let 1 = S1 > S2 > · · ·> SJ+1 denote the baseline survival functions (i.e.,
corresponding to Z = 0), evaluated at the left boundaries of the intervals
[0, τ1), [τ1, τ2), . . . , [τJ ,∞). Then, for subject i, with corresponding covariate
vector zi, S
(i)
j = (Sj)
ez
′
i
β
. Thus, the log-likelihood function for a random
sample of N subjects can be expressed as
l(S,β) =
N∑
i=1
log
(
J+1∑
j=1
Dij(Sj)
ez
′
i
β
)
.(2.4)
The elements of the D matrix are functions of the observed data includ-
ing the visit times and corresponding self-reported results, as well as the
constants ϕ0, ϕ1. Assuming that ϕ0, ϕ1 are known constants, the maximum
likelihood estimates of the unknown parameters β1, . . . , βP , S2, . . . , SJ+1 can
be obtained by numerical maximization of the log-likelihood function, sub-
ject to the constraints that 1 > S2 > S3 > · · · > SJ+1 > 0. Statistical infer-
ence regarding the parameters of interest (β1, . . . , βP , S2, . . . , SJ+1) can be
made by using asymptotic properties of the maximum likelihood estimators
[Cox and Hinkley (1979)]. The estimated covariance matrix of the maximum
likelihood estimates can be obtained by inverting the Hessian matrix. Hy-
pothesis tests regarding the unknown parameters can be carried out using
the likelihood ratio or Wald test.
2.2. Misclassification at study entry. In this section we incorporate the
setting in which a self-report of being event(disease)-free at baseline or study
entry is used as the inclusion criterion. The evaluation of the association
between statin use and risk of incident diabetes in the WHI was based on all
women who self-reported to be diabetes-free at baseline [Culver et al. (2012)].
However, diabetes self-reports at study entry in the WHI have been found
to be less than perfect—the study by Margolis et al. (2008) found that the
negative predictive value of prevalent diabetes at baseline was approximately
97%, that is, 3% of women who self-reported as being diabetes-free were, in
fact, diabetic. In this situation, the assumption that S(0) = 1 is invalid.
For the ith subject, let Gi denote the baseline binary self-report, where
Gi = 1 denotes a self-report indicating that the event of interest has already
occurred and Gi = 0 denotes otherwise. Similarly, let Bi denote the true
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event status at baseline. In other words, Bi = 1
def
= Xi ≤ 0 and Bi = 0
def
= Xi >
0. Consider a subject who has a negative self-report at baseline (i.e., Gi = 0)
and is thus included in the data set. As before, let the vector of observed
self-reports for the ith subject be denoted by Ri. Let the negative predictive
value of self-reports at baseline be denoted by η, that is, Pr(Bi = 0|Gi = 0) =
η. Then the likelihood function for the ith subject can be expressed as
Li = Pr(Ri, ti, ni|Gi = 0)
= ηPr(Ri, ti, ni|Bi = 0,Gi = 0)(2.5)
+ (1− η)Pr(Ri, ti, ni|Bi = 1,Gi = 0).
We assume that subjects who self-report negative (Gi = 0) and are truly neg-
ative for event at baseline (Bi = 0) are a random sample from all subjects
who are true negative at baseline. Then we have Pr(Ri, ti, ni|Bi = 0,Gi =
0) = Pr(Ri, ti, ni|Bi = 0), which corresponds to the likelihood function de-
rived in Section 2.1. Thus, Pr(Ri, ti, ni|Bi = 0,Gi = 0) =
∑J+1
j=1 Dij(Sj)
ez
′
i
β
.
Moreover, Pr(Ri, ti, ni|Bi = 1,Gi = 0) =Di1(S1)
ez
′
i
β
.
The likelihood function for the ith subject has the form
Li(β,S) = η
J+1∑
j=1
Dij(Sj)
ez
′
i
β
+ (1− η)Di1(S1)
ez
′
i
β
(2.6)
=
J+1∑
j=1
D′ij(Sj)
ez
′
i
β
,
where D′i1 =Di1 and D
′
ij = ηDij for j > 1. Thus, the likelihood function in-
corporating baseline misclassification has the same general form as in equa-
tion (2.4). The likelihood function in equation (2.4) can be obtained as a
special case when η = 1 in equation (2.6).
2.3. Time-varying covariates. We consider the situation where covariate
values can change with time and are collected at each visit. Let zij denote
the p × 1 vector of covariate values for subject i at time τj . In extending
the likelihood function [equation (2.4)] to handle time-varying covariates, we
make the additional assumption that the values of the covariates zij remain
constant during the interval [τj, τj+1). Let Λj denote the cumulative hazard
function during the period of [τj , τj+1) for the subjects in the reference
group (i.e., Z= 0). Under the model λzi(t) = λ0(t)e
βzi , the corresponding
cumulative hazard function during the period [τj , τj+1) for subject i is equal
to Λj exp(z
′
ijβ). The survival function at τj−1 can then be expressed as
S
(i)
j = exp
(
−
j−2∑
j′=0
Λj′ exp(z
′
ij′β)
)
,
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where j = 2, . . . , J + 1, where S
(i)
1 = 1. The log-likelihood function can be
expressed as a function of the derived S
(i)
j ,
l(S,β) =
N∑
i=1
log
(
J+1∑
j=1
DijS
(i)
j
)
.
The log-likelihood function can be optimized with respect to the parameters
Λ0, . . . ,ΛJ−1 and β1, . . . , βP subject to constraints Λj ≥ 0. In practice, if a
subject has missing visits or missing covariate values at some visits, one
can carry forward the last observation as one approach to impute missing
covariate values. However, unless the proportion of missing is very small,
these ad hoc approaches toward handling missing data may result in biased
estimates of parameters and their associated standard errors.
2.4. Unknown sensitivity and specificity. Identifiability of the sensitiv-
ity and specificity parameters is closely tied to the study design and the
paradigm used for determining number and timing of visits (tests). For ex-
ample, in several epidemiological cohorts in which self-reported outcomes of
chronic diseases such as diabetes are collected, data collection on the inci-
dence of the condition ceases following the first positive self-report. In such
study designs, it is implicitly assumed that self-reports following the first
positive self-report will be positive with probability 1, thus, subsequent self-
reports are noninformative. In settings that incorporate an adaptive testing
paradigm, the form of the likelihood is shown in equation (2.4)—while this
is a function of the constants ϕ1, ϕ0 that characterize the sensitivity and
specificity of self-reports, these parameters cannot be estimated jointly with
the parameters of interest, namely, β1, . . . , βp, S2, . . . , SJ+1. If the sensitiv-
ity and specificity parameters are unknown, an augmented study design in
which a subset of subjects are given a perfect diagnostic test in addition to
self-reported questionnaires could be considered. In these studies, the pa-
rameters ϕ1, ϕ0 can be jointly estimated with the unknown parameters of
interest. A similar approach was proposed by Lyles et al. (2011) for mismea-
sured outcomes in logistic regression models.
In other clinical settings, the mismeasured outcome arises from laboratory-
based diagnostic tests characterized by imperfect sensitivity and specificity.
When the testing paradigm involves giving the diagnostic test according to
a predetermined testing schedule, the form of the likelihood can be shown to
be identical to that in equation (2.4) [Balasubramanian and Lagakos (2003)].
In this case, it is possible to observe seemingly inconsistent patterns of test
results where one or more negative test results follow a positive result. Ex-
amples include data collected from DNA PCR assays to detect HIV infection
in infants in pediatric HIV clinical trials. Studies in which subjects are tested
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according to a predetermined testing schedule, the sensitivity, specificity pa-
rameters (ϕ1, ϕ0) can be jointly estimated with the unknown parameters of
interest [Meier, Richardson and Hughes (2003)].
3. Simulation. In this section we present results from simulation studies
to illustrate the effects of (1) error-prone self-reported outcomes; and (2)
misclassification at study entry. We present the effects of these factors with
regard to the bias associated with the estimated regression parameter of
interest.
3.1. Effects of error-prone self-reported outcomes. We present average
results from 1000 simulated data sets in which 1000 subjects were randomly
assigned to two exposure groups with equal proportion, assuming all sub-
jects were event-free at baseline (i.e., Xi > 0 for all i). We assumed that there
is a single binary covariate of interest Zi, corresponding to the exposure sta-
tus of the ith subject. The associated regression parameter in the likelihood
[equation (2.4)] was set to β = 1. For each subject, self-reported question-
naires were collected at 8 scheduled visits over a duration of 8 years, each
with a random missing probability of 30%. All self-reports following the first
positive report were assumed to be positive with probability 1. The simula-
tion mechanism assumed that the time to the event of interest X followed an
exponential distribution. The hazard rate λ governing the time to the event
of interest in the reference group (Zi = 0) was set to equal 0.0132 or 0.0866,
corresponding to a cumulative incidence by study end (1−SJ+1) of 0.10 or
0.50, respectively. As shown in Table 1, we compare results across several
sets of values for the parameters (ϕ1, ϕ0), corresponding to the sensitivity
and specificity of self-reports.
In Table 1, for each parameter setting, we present estimates of bias, associ-
ated standard error, root mean square error (RMSE) and coverage probabil-
ity associated with the estimation of β. Coverage probability was calculated
as the proportion of data sets in which the 95% confidence interval for β
contains its true value. We compare results from two sets of analyses for
estimating β: (a) maximizing the likelihood presented in equation (2.4), as-
suming that the true values of ϕ1, ϕ0 are known; and (b) maximizing the
likelihood presented in equation (2.4), assuming that self-reports are perfect
(i.e., ϕ1 = ϕ0 = 1). In general, when the true values of ϕ0, ϕ1 are incorpo-
rated into the analysis, the estimates of β are nearly unbiased. Similarly,
the true coverage probability corresponding to a 95% confidence interval is
close to its nominal value. On the other hand, when self-reports are incor-
rectly assumed to be perfect, the estimates of β may be significantly biased,
especially in settings where ϕ0 is low. When ϕ0≪ 1, early false positive self-
reports result in significant loss of information due to premature cessation
of data collection. In this case, coverage probabilities deviated significantly
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Table 1
Comparing estimates of the regression parameter β from an “adjusted” analysis that
accounts for the error in self-reported outcomes to an “unadjusted” analysis that
incorrectly assumes that self-reports are perfect
ϕ1 ϕ0 SJ+1 Analysis type Bias (%) Std Err RMSE Coverage (%)
0.75 1.00 0.90 Adjusted 0.3 0.17 0.17 96.8
0.75 1.00 0.90 Unadjusted 0.1 0.17 0.17 97.0
1.00 0.75 0.90 Adjusted −6.7 0.82 0.82 93.8
1.00 0.75 0.90 Unadjusted −90.2 0.07 0.90 0.0
0.61 0.995 0.90 Adjusted 1.4 0.21 0.22 94.9
0.61 0.995 0.90 Unadjusted −16.4 0.17 0.23 82.9
0.75 1.00 0.50 Adjusted 0.1 0.09 0.09 95.1
0.75 1.00 0.50 Unadjusted −1.9 0.09 0.09 93.5
1.00 0.75 0.50 Adjusted 0.2 0.19 0.19 94.4
1.00 0.75 0.50 Unadjusted −59.2 0.07 0.60 0.0
0.61 0.995 0.50 Adjusted 0.5 0.09 0.09 94.2
0.61 0.995 0.50 Unadjusted −6.9 0.08 0.11 86.7
from 95%. Last, incorporating the uncertainty in error-prone self-reports
increases the standard error of the maximum likelihood estimates of β.
We note that while the true event times were simulated based on the ex-
ponential distribution, the proposed methods make no distribution assump-
tions. Thus, the performance of the proposed methods does not depend on
the underlying distributions of the event times. When event times were sim-
ulated based on a Weibull distribution, similar results were observed (results
available upon request).
3.2. Effects of misclassification at study entry. In this simulation we in-
corporate the setting in which an error-prone, self-report of being
event(disease)-free at study entry is used as the inclusion criterion. As be-
fore, let η denote the negative predictive value of the baseline self-report.
That is, each subject included in the study has a probability of 1 − η of
having already experienced the event of interest prior to study entry. Each
simulated data set included 1000 subjects, of whom 1000× (1− η) had al-
ready experienced the event of interest prior to entry into the study (i.e.,
X < 0). The data were simulated as described in Section 3.1, where ϕ1 = 0.61
and ϕ0 = 0.995. We compare results for various settings by varying the cu-
mulative incidence of the event of interest (1− SJ+1) to equal 0.10 or 0.50,
and by varying the value of η to equal 0.99, 0.96 or 0.93.
Table 2 presents the simulation results, averaged over 1000 data sets. We
present results from an “adjusted” model that properly accounts for mis-
classification at baseline based on the likelihood presented in equation (2.6)
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Table 2
Comparing estimates of the regression parameter β from an “adjusted” analysis that
incorporates the possibility of misclassification at baseline to an “unadjusted” analysis
that incorrectly assumes that all subjects are event-free at study entry or that η = 1. We
assume that ϕ1 = 0.61 and ϕ0 = 0.995
SJ+1 η Analysis type Bias (%) Std Err RMSE Coverage (%)
0.90 0.99 Adjusted 2.6 0.22 0.23 95.0
0.90 0.99 Unadjusted −4.5 0.20 0.21 94.1
0.90 0.96 Adjusted 1.2 0.24 0.24 95.8
0.90 0.96 Unadjusted −22.9 0.17 0.29 72.7
0.90 0.93 Adjusted 0.1 0.25 0.25 95.2
0.90 0.93 Unadjusted −36.4 0.15 0.40 36.3
0.50 0.99 Adjusted 0.0 0.09 0.09 95.2
0.50 0.99 Unadjusted −1.5 0.09 0.09 94.1
0.50 0.96 Adjusted 0.1 0.10 0.10 94.2
0.50 0.96 Unadjusted −5.7 0.09 0.11 89.2
0.50 0.93 Adjusted 0.6 0.10 0.10 94.1
0.50 0.93 Unadjusted −9.4 0.09 0.13 80.9
compared to the model in equation (2.4) that incorrectly assumes that η = 1
(denoted “unadjusted”). In both models, the true values of the sensitivity
and specificity are assumed. As expected, the adjusted model is nearly unbi-
ased and has uniformly lower bias when compared to the unadjusted model.
The bias of the unadjusted model increases with decreasing values of neg-
ative predictive value (η), and it is more pronounced when the cumulative
incidence is low (1−SJ+1 = 0.10). In general, the inclusion of subjects who
have already experienced the event of interest at study entry results in the
exposure groups becoming less distinguishable. Thus, ignoring this issue in
data analysis results in estimates of exposure effects (β) that are biased
toward the null. In contrast, incorporating the effect of baseline misclassi-
fication increases the standard error of βˆ. The effects on the bias and the
standard error of βˆ are reflected in the RMSE values—the adjusted model
has smaller RMSE than the unadjusted model in all settings except when
SJ+1 = 0.9 and η = 0.99. The coverage probability of the adjusted model
is approximately 95% in all settings considered in this study. However, the
coverage probability of the unadjusted model decreases with decreasing neg-
ative predictive value (η) due to increased bias.
4. Application: Risk of diabetes mellitus with statin use in the Women’s
Health Initiative.
Background. We analyze data collected on 152,830 women from the
Women’s Health Initiative (WHI) to evaluate the effects of statin use on
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the risk of incident diabetes mellitus (DM). Culver et al. (2012) reported an
increased risk of incident DM with baseline statin use (multivariate-adjusted
HR, 1.48; 95% CI, 1.38–1.59). These results were based on Cox proportional
hazards models where the time to event variable was calculated as the in-
terval between enrollment date and the earliest of the following: (1) date
of annual medical history update when new diabetes is self-reported (posi-
tive outcome); (2) date of last annual medical update during which diabetes
status can be ascertained (censorship); or (3) date of death (censorship).
The methods used in Culver et al. (2012) were based on the assumptions
that: (1) all subjects who self-reported as being diabetes-free at baseline
were truly not diabetic (i.e., η = 1); and (2) the self-reports of incident dia-
betes at each follow-up visit were error-free (i.e., ϕ1 = ϕ0 = 1). We compare
the results from Culver et al. (2012) to results based on application of the
likelihood-based methods described in this paper.
Diabetes self-reports. Prevalent diabetes at baseline and incident dia-
betes were assessed through self-reported questionnaires in the WHI. At
baseline and at each annual visit, participants were asked whether she has
ever received a physician diagnosis of and/or treatment for diabetes when
not pregnant since the time of the last self-report (visit). Using data from
a WHI substudy, estimates of sensitivity, specificity and baseline negative
predictive value of self-reported diabetes outcomes were obtained by com-
paring self-reported outcomes to fasting glucose levels and medication data
[Margolis et al. (2008)]. A woman was considered to be truly diabetic if
she had either taken anti-diabetic medication and/or had a fasting glucose
level ≥126 mg/dl. From a representative subset of 5485 women, with in-
formation at baseline on self-reported diabetes, fasting glucose levels and
medication inventory, we estimated that self-reports have a sensitivity of
0.61, the specificity of 0.995, and a negative predictive value of 0.96 at base-
line. These estimated parameter values are used in our analysis. We used the
following definitions: (1) sensitivity: proportion of diabetics with a positive
self-report; (2) specificity: proportion of nondiabetics with a negative self-
report; and (3) negative predictive value: proportion of subjects who were
diabetes-free among those with a negative self-report. In practice, estimat-
ing measurement error parameters from validation studies should proceed
with caution as validation studies may differ from their study populations.
Methods. The analysis data set included 152,830 women out of a total
of 161,808 women enrolled in the WHI. Women who self-reported diabetes
at baseline or those who ever took Cerivastatin were excluded. In addition,
women with missing data at baseline on diabetes status or medication in-
ventory were excluded [Culver et al. (2012)]. The results presented here are
based on follow-up until 2010. The median duration of follow-up was 12.1
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years, including 1,688,967 person-years of total follow-up. During the course
of follow-up, 10.4% of women self-reported being diagnosed with diabetes.
Information on statin use was obtained from medical inventory information,
which was available for selected follow-up years. Information on statin use
was available for 152,830, 59,505, 128,507, 55,043 and 12,039 subjects at
baseline, years 1, 3, 6 and 9, respectively. Models included either baseline
statin use or statin use as a time-varying covariate—in the latter case, the
most recent medication inventory data available was carried forward for time
points at which current medication use was not collected. In multivariable
models, other covariates included race, smoking status, alcohol intake, age,
education, WHI study, BMI, recreational physical activity, dietary energy
intake, family history of diabetes and hormone therapy use [Culver et al.
(2012)]. We assumed that self-reports following the first report of incident
diabetes are noninformative. Annual visit times were rounded to the nearest
year in order to limit the number of parameters estimated to describe the
baseline survival function (S2, . . . , SJ+1).
Results. Table 3 presents the estimated hazard ratio (95% confidence in-
terval) for statin use by modeling statin use at baseline or as a time-varying
covariate. For each, we present results from univariable models as well as
multivariable models incorporating potential confounders. In each setting,
the results from the methods proposed in this paper are compared to results
from Cox models. In all models, by incorporating the imperfect sensitivity
and specificity of self-reports and the potential misclassification at study en-
try, the hazard ratio of statin use is consistently increased when comparing
to the corresponding Cox models. Using the proposed methods in equation
Table 3
Analysis of the effects of statin use on incident diabetes mellitus risk in the WHI
Univariable/ Hazard ratio
Statin variable type Type of analysis multivariable∗ N (95% CI)
Baseline statin Proposed model Univariable 152,830 2.33 (2.12, 2.56)
Baseline statin Proposed model Multivariable 138,338 1.81 (1.65, 1.99)
Baseline statin Cox model Univariable 152,830 1.69 (1.60, 1.78)
Baseline statin Cox model Multivariable 138,338 1.54 (1.46, 1.63)
Time-varying statin Proposed model Univariable 152,830 2.49 (2.31, 2.68)
Time-varying statin Proposed model Multivariable 138,338 1.88 (1.75, 2.02)
Time-varying statin Cox model Univariable 152,830 1.65 (1.59, 1.72)
Time-varying statin Cox model Multivariable 138,338 1.48 (1.42, 1.54)
∗Covariates adjusted include race, smoking status, alcohol intake, age, education, WHI
study, BMI, recreational physical activity, dietary energy intake, family history of diabetes
and hormone therapy use.
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(2.6), the hazard ratio for baseline statin use from univariate analysis was
2.33 (95% CI: 2.12–2.56). In the multivariable model, the hazard ratio of
baseline statin use was 1.81 (95% CI: 1.65–1.99), suggesting a relatively
strong confounding effect. When statin use was modeled as a time-varying
covariate, the hazard ratios of statin use from univariate and multivariate
models were 2.49 (95% CI: 2.31–2.68) and 1.88 (95% CI: 1.75–2.02), respec-
tively.
The goodness of fit of the multivariable model incorporating statin use as
a time-varying covariate was assessed in an augmented model that included 2
additional terms corresponding to the interactions of time periods (in years)
(3,6] and (6,16] with statin use. This model allows the effect of statin use to
vary between the time periods (0,3], (3,6] and (6,16] years. The Wald test p
values corresponding to the interactions of statin use with the time periods
(3,6] and (6,16] were 0.89 and 0.11, respectively; these results indicate that
the augmented model provided no improvement in fit when compared to the
model without the additional interaction terms.
To evaluate how the results depend on the choice of parameters such as
sensitivity, specificity and baseline negative predictive value of self-reported
diabetes, we performed a sensitivity analysis by varying each of these param-
eters. Table 4 presents how the estimated hazard ratio of statin use changes
with different combinations of the parameters. Statin use was modeled as
a time-varying covariate while simultaneously adjusting for potential con-
founders. We observed that the estimated hazard ratio of statin use is most
sensitive to change in specificity. This is largely due to the fact that the
cumulative incidence of diabetes was low (10.4%), and thus false positive
self-reports due to imperfect specificity have a big influence on estimated
parameters. In general, the hazard ratio of statin use decreases as specificity
increases. Changes in sensitivity and negative predictive value at baseline
have modest effects on the resulting model fit.
The models presented here can be implemented using our freely available
R software package icensmis [Gu and Balasubramanian (2013)] as described
in the supplemental material [Gu, Ma and Balasubramanian (2015)].
5. Discussion. Due to cost considerations, the use of self-reported out-
comes is common to diagnose prevalent and incident disease in large-scale
epidemiologic investigations. In this paper we present a likelihood-based
framework to model the association of a time-varying covariate with a time
to event outcome, that is observed through periodically collected, error-
prone, self-reported data. We incorporate the possibility of erroneous inclu-
sion of subjects who have already experienced the event of interest prior
to study entry as a result of the use of self-reported outcomes at baseline
in determining the study population. R code for implementing the mod-
els proposed here are presented in the supplemental material [Gu, Ma and
Balasubramanian (2015)].
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Table 4
Statin use versus risk of incident diabetes mellitus in the WHI—sensitivity analysis for
varying sensitivity (ϕ1), specificity (ϕ0) and baseline negative predictive value (η)
associated with diabetes self-reports. All models incorporate statin use as a time-varying
covariate and adjust for potential confounders
Negative predictive Hazard ratio
Sensitivity (ϕ1) Specificity (ϕ0) value (η) (95% CI)
0.50 0.993 0.96 2.11 (1.92, 2.31)
0.50 0.993 0.98 2.10 (1.92, 2.30)
0.50 0.995 0.96 1.93 (1.79, 2.08)
0.50 0.995 0.98 1.93 (1.79, 2.07)
0.50 0.997 0.96 1.76 (1.65, 1.88)
0.50 0.997 0.98 1.77 (1.66, 1.88)
0.61 0.993 0.96 2.05 (1.88, 2.24)
0.61 0.993 0.98 2.06 (1.89, 2.24)
0.61 0.995 0.96 1.88 (1.75, 2.02)
0.61 0.995 0.98 1.89 (1.76, 2.03)
0.61 0.997 0.96 1.73 (1.63, 1.84)
0.61 0.997 0.98 1.74 (1.64, 1.84)
0.70 0.993 0.96 2.02 (1.85, 2.20)
0.70 0.993 0.98 2.03 (1.86, 2.21)
0.70 0.995 0.96 1.86 (1.73, 2.00)
0.70 0.995 0.98 1.87 (1.74, 2.00)
0.70 0.997 0.96 1.71 (1.61, 1.82)
0.70 0.997 0.98 1.72 (1.62, 1.82)
We presented results from simulation studies to assess the impact of ignor-
ing error in self-reported outcomes—in all cases considered, the use of sta-
tistical models that correctly accommodate the error inherent in self-reports
resulted in nearly unbiased estimates of the regression parameter of interest.
The largest bias as a result of ignoring error in self-reported outcomes was
found in settings where the cumulative incidence was low and specificity was
less than perfect. Models that correctly accommodate error in self-reports
also resulted in increased variance of the estimated regression parameters.
However, in most settings, the RMSE values that combine the impact of
bias and variance of the estimated regression parameter favored the use of
methods that appropriately account for error in self-reported outcomes.
The methods proposed in this paper were applied to prospective data
from 152,830 women enrolled in the WHI to evaluate the effect of statin use
and risk of incident diabetes. By accounting for the imperfect sensitivity,
specificity and negative predictive value at baseline for diabetes self-reports,
we observed that the hazard ratio for statin use was significantly larger
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than that estimated in naive analyses that ignored the error in self-reported
outcomes. In particular, the hazard ratio of statin use in a multivariable
model adjusted for potential confounders was 1.88 (95% CI: 1.75–2.02) as
compared to the multivariable hazard ratio estimate from Cox model 1.48
(95% CI: 1.42–1.54).
In the methods developed here, we assumed that the sensitivity and speci-
ficity of self-reported outcomes are invariant with respect to time since entry
and independent of covariates. In many real-world settings, this assumption
may result in over-simplified models, particularly in applications in which
visits are unequally spaced. In addition, the methods developed here as-
sumed that the parameters governing the characteristics of self-reported
outcomes are known. However, in many cases these are estimated values—
in this context, it would be useful to extend the methods proposed here to
consider study designs including validation subsets that would allow joint es-
timation of the sensitivity and specificity of self-reported outcomes together
with the other parameters of interest.
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SUPPLEMENTARY MATERIAL
Tutorial for using the R package icensmis (DOI: 10.1214/15-AOAS810SUPP;
.pdf). We present a short tutorial using the R package icensmis to perform
the analysis described in this paper.
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